Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments
In the past decade, several novel therapies have shown promise in treating generalized myasthenia gravis (MG); however, no head-to-head prospective studies have compared their efficacy and safety. To assist clinicians in navigating this complex treatment landscape, we sought to compare treatments while accounting for differences in trial populations.
Authors
- Sheena Hussain
- Melissa Funaro (ORCID: https://orcid.org/0000-0001-6846-4846)
- Richard J. Nowak (ORCID: https://orcid.org/0000-0001-8438-482X)
- Bhaskar Roy (ORCID: https://orcid.org/0000-0003-3604-6310)
- Matteo Rosati (ORCID: https://orcid.org/0000-0002-3963-6845)
- Nilay P. McLaren (ORCID: https://orcid.org/0000-0002-7728-641X)
- Wayne Zhong (ORCID: https://orcid.org/0009-0004-8458-9904)
Institutions
- KPC Medical College and Hospital (IN)
- Yale University (US)
- Medical College and Hospital, Kolkata (IN)
Publication Details
- Journal
- Neurology
- Published
- 2026-07-17
- DOI
- https://doi.org/10.1212/wnl.0000000000218351
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00